We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has issued a warning letter to Nendingen, Germany-based laparoscopy devicemaker Getsch+Hiller Medizintechnik (GH) for unapproved product changes, the lack of a design history file and other lapses observed during a July 2022 inspection.
GE Healthcare is acquiring Caption Health, a California-based company that uses artificial intelligence (AI) solutions for early detection of heart disease in ultrasound scans.
aragonix Technologies’ LUNGguard donor lung preservation system recently saw its first use for a pediatric case in which donor lungs procured overnight were preserved with the system, allowing for next day transplant surgery.
Abbott is expanding its portfolio of cardiovascular devices through an $890 million purchase of St. Paul, Minn.-based Cardiovascular Systems (CSI) and its orbital atherectomy system.
A jury in the U.S. District Court for the Central District of California has awarded cardiac devicemaker Colibri Heart Valve $106.5 million for infringement by Medtronic’s CoreValve devices of Colibri’s patents for a self-expanding valve device used to replace diseased heart valves.
The FDA has sent neurovascular device company MicroVention a warning letter after the agency was not satisfied with the company’s responses to a Form 483 inspection report which noted problems with validations, correction and preventive actions, and other lapses.